Several natural compounds or their synthetic analogs, such as isoflavones and bisflavones, have been demonstrated to overcome cisplatin resistance in ovarian carcinoma through suppression of the PI3K/AKT/mTOR signaling [33–35]. Here, PIK3CA is linked to ovarian carcinoma.